Caribou Historical Balance Sheet

CRBU Stock

USD 1.17 0.01 0.86%

Trend analysis of Caribou Biosciences balance sheet accounts such as Short Long Term Debt Total of 32.7 M, Other Current Liabilities of 14.2 M or Total Current Liabilities of 23 M provides information on Caribou Biosciences' total assets, liabilities, and equity, which is the actual value of Caribou Biosciences to its prevalent stockholders. By breaking down trends over time using Caribou Biosciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Caribou Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Caribou Biosciences is a good buy for the upcoming year.

Caribou Biosciences Inventory

(53.5 Million)

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caribou Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Caribou Stock please use our How to Invest in Caribou Biosciences guide.

About Caribou Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Caribou Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Caribou Biosciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Caribou Biosciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Caribou currently owns. An asset can also be divided into two categories, current and non-current.

Caribou Biosciences Balance Sheet Chart

At this time, Caribou Biosciences' Property Plant And Equipment Gross is comparatively stable compared to the past year. Accumulated Other Comprehensive Income is likely to gain to about 28.4 K in 2025, whereas Total Current Liabilities is likely to drop slightly above 23 M in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Common Stock Shares Outstanding Long Term Debt

Add Fundamental

Total Assets

Total assets refers to the total amount of Caribou Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Caribou Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Caribou Biosciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Caribou Biosciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Long Term Debt

Long-term debt is a debt that Caribou Biosciences has held for over one year. Long-term debt appears on Caribou Biosciences balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Caribou Biosciences balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most accounts from Caribou Biosciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Caribou Biosciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caribou Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Caribou Stock please use our How to Invest in Caribou Biosciences guide.At this time, Caribou Biosciences' Property Plant And Equipment Gross is comparatively stable compared to the past year. Accumulated Other Comprehensive Income is likely to gain to about 28.4 K in 2025, whereas Total Current Liabilities is likely to drop slightly above 23 M in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	27.7M	27.1M	31.2M	32.7M
Total Assets	373.8M	432.2M	497.0M	296.2M

Short Long Term Debt Total Total Assets

Caribou Biosciences balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		0.79	0.93	0.99	1.0	0.96	0.99	0.79	0.78	-0.35	-0.9	0.21	0.58	0.93	0.93	0.93	0.99	0.34	0.99	0.73	0.9	-0.84	-0.94	0.94	0.94	0.76
Short Long Term Debt Total	0.79		0.87	0.85	0.77	0.65	0.72	1.0	0.56	0.24	-0.96	-0.29	0.08	0.9	0.92	0.89	0.74	-0.17	0.79	0.79	0.95	-0.58	-0.94	0.79	0.91	0.94
Other Current Liab	0.93	0.87		0.96	0.93	0.83	0.88	0.88	0.57	-0.04	-0.95	0.12	0.29	0.94	0.97	0.97	0.89	0.08	0.93	0.89	0.92	-0.74	-0.92	0.88	0.92	0.85
Total Current Liabilities	0.99	0.85	0.96		0.98	0.94	0.97	0.85	0.78	-0.22	-0.94	0.09	0.48	0.97	0.97	0.96	0.97	0.27	0.99	0.75	0.92	-0.78	-0.96	0.97	0.95	0.85
Total Stockholder Equity	1.0	0.77	0.93	0.98		0.97	0.99	0.78	0.78	-0.37	-0.89	0.23	0.6	0.92	0.92	0.92	0.99	0.35	0.99	0.72	0.89	-0.85	-0.93	0.94	0.93	0.74
Other Liab	0.96	0.65	0.83	0.94	0.97		0.98	0.66	0.85	-0.55	-0.8	0.31	0.75	0.84	0.81	0.81	0.98	0.58	0.96	0.57	0.8	-0.86	-0.86	0.95	0.88	0.64
Net Tangible Assets	0.99	0.72	0.88	0.97	0.99	0.98		0.72	0.84	-0.44	-0.84	0.23	0.66	0.91	0.89	0.89	1.0	0.44	0.99	0.64	0.84	-0.83	-0.91	0.94	0.9	0.7
Property Plant And Equipment Net	0.79	1.0	0.88	0.85	0.78	0.66	0.72		0.53	0.22	-0.96	-0.22	0.1	0.89	0.91	0.88	0.74	-0.18	0.79	0.82	0.97	-0.63	-0.93	0.77	0.93	0.91
Current Deferred Revenue	0.78	0.56	0.57	0.78	0.78	0.85	0.84	0.53		-0.51	-0.61	-0.08	0.7	0.76	0.65	0.66	0.84	0.59	0.81	0.2	0.62	-0.58	-0.76	0.85	0.71	0.6
Net Debt	-0.35	0.24	-0.04	-0.22	-0.37	-0.55	-0.44	0.22	-0.51		-0.04	-0.67	-0.94	-0.05	0.01	0.0	-0.44	-0.9	-0.32	0.18	-0.02	0.53	0.07	-0.3	-0.16	0.25
Retained Earnings	-0.9	-0.96	-0.95	-0.94	-0.89	-0.8	-0.84	-0.96	-0.61	-0.04		0.03	-0.27	-0.93	-0.95	-0.93	-0.86	-0.03	-0.9	-0.82	-0.98	0.73	0.97	-0.88	-0.97	-0.88
Accounts Payable	0.21	-0.29	0.12	0.09	0.23	0.31	0.23	-0.22	-0.08	-0.67	0.03		0.58	-0.12	-0.06	-0.06	0.23	0.52	0.15	0.15	0.0	-0.52	0.09	0.06	0.07	-0.38
Cash	0.58	0.08	0.29	0.48	0.6	0.75	0.66	0.1	0.7	-0.94	-0.27	0.58		0.3	0.25	0.25	0.67	0.87	0.55	0.05	0.34	-0.75	-0.36	0.54	0.46	0.03
Non Current Assets Total	0.93	0.9	0.94	0.97	0.92	0.84	0.91	0.89	0.76	-0.05	-0.93	-0.12	0.3		0.99	0.99	0.9	0.12	0.96	0.73	0.9	-0.63	-0.97	0.93	0.91	0.92
Non Currrent Assets Other	0.93	0.92	0.97	0.97	0.92	0.81	0.89	0.91	0.65	0.01	-0.95	-0.06	0.25	0.99		1.0	0.89	0.02	0.94	0.83	0.92	-0.66	-0.96	0.89	0.92	0.91
Other Assets	0.93	0.89	0.97	0.96	0.92	0.81	0.89	0.88	0.66	0.0	-0.93	-0.06	0.25	0.99	1.0		0.89	0.04	0.95	0.81	0.89	-0.63	-0.95	0.89	0.89	0.9
Cash And Short Term Investments	0.99	0.74	0.89	0.97	0.99	0.98	1.0	0.74	0.84	-0.44	-0.86	0.23	0.67	0.9	0.89	0.89		0.43	0.99	0.65	0.86	-0.85	-0.91	0.94	0.92	0.71
Net Receivables	0.34	-0.17	0.08	0.27	0.35	0.58	0.44	-0.18	0.59	-0.9	-0.03	0.52	0.87	0.12	0.02	0.04	0.43		0.34	-0.25	0.04	-0.43	-0.13	0.43	0.18	-0.11
Common Stock Total Equity	0.99	0.79	0.93	0.99	0.99	0.96	0.99	0.79	0.81	-0.32	-0.9	0.15	0.55	0.96	0.94	0.95	0.99	0.34		0.7	0.88	-0.79	-0.94	0.96	0.92	0.79
Common Stock Shares Outstanding	0.73	0.79	0.89	0.75	0.72	0.57	0.64	0.82	0.2	0.18	-0.82	0.15	0.05	0.73	0.83	0.81	0.65	-0.25	0.7		0.83	-0.67	-0.72	0.6	0.78	0.73
Short Term Investments	0.9	0.95	0.92	0.92	0.89	0.8	0.84	0.97	0.62	-0.02	-0.98	0.0	0.34	0.9	0.92	0.89	0.86	0.04	0.88	0.83		-0.8	-0.95	0.85	0.99	0.85
Non Current Liabilities Total	-0.84	-0.58	-0.74	-0.78	-0.85	-0.86	-0.83	-0.63	-0.58	0.53	0.73	-0.52	-0.75	-0.63	-0.66	-0.63	-0.85	-0.43	-0.79	-0.67	-0.8		0.71	-0.73	-0.85	-0.45
Inventory	-0.94	-0.94	-0.92	-0.96	-0.93	-0.86	-0.91	-0.93	-0.76	0.07	0.97	0.09	-0.36	-0.97	-0.96	-0.95	-0.91	-0.13	-0.94	-0.72	-0.95	0.71		-0.93	-0.96	-0.88
Other Current Assets	0.94	0.79	0.88	0.97	0.94	0.95	0.94	0.77	0.85	-0.3	-0.88	0.06	0.54	0.93	0.89	0.89	0.94	0.43	0.96	0.6	0.85	-0.73	-0.93		0.91	0.82
Other Stockholder Equity	0.94	0.91	0.92	0.95	0.93	0.88	0.9	0.93	0.71	-0.16	-0.97	0.07	0.46	0.91	0.92	0.89	0.92	0.18	0.92	0.78	0.99	-0.85	-0.96	0.91		0.83
Total Liab	0.76	0.94	0.85	0.85	0.74	0.64	0.7	0.91	0.6	0.25	-0.88	-0.38	0.03	0.92	0.91	0.9	0.71	-0.11	0.79	0.73	0.85	-0.45	-0.88	0.82	0.83

Click cells to compare fundamentals

Caribou Biosciences Account Relationship Matchups

Caribou Biosciences balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	36.0M	442.4M	373.8M	432.2M	497.0M	296.2M
Short Long Term Debt Total	1.6M	259K	27.7M	27.1M	31.2M	32.7M
Other Current Liab	9.0M	13.1M	15.1M	21.1M	24.3M	14.2M
Total Current Liabilities	12.4M	25.8M	28.1M	28.3M	32.5M	23.0M
Total Stockholder Equity	(23.4M)	387.8M	300.9M	368.4M	423.7M	229.0M
Property Plant And Equipment Net	3.5M	4.9M	34.9M	40.5M	46.5M	48.8M
Current Deferred Revenue	161K	8.7M	9.9M	2.8M	3.3M	4.9M
Net Debt	(14.4M)	(240.2M)	(30.6M)	(24.1M)	(27.7M)	(29.0M)
Retained Earnings	(30.9M)	(97.8M)	(197.2M)	(299.3M)	(269.4M)	(255.9M)
Accounts Payable	2.6M	4.0M	1.1M	3.1M	2.8M	2.1M
Cash	16.0M	240.4M	58.3M	51.2M	58.8M	89.5M
Non Current Assets Total	11.7M	51.2M	113.5M	93.4M	107.4M	60.4M
Non Currrent Assets Other	612K	975K	1.5M	1.6M	1.8M	1.2M
Cash And Short Term Investments	16.0M	413.5M	317.0M	328.8M	378.2M	247.5M
Net Receivables	5.2M	8.1M	4.7M	3.9M	3.5M	4.1M
Short Term Investments	0.0	135.4M	189.3M	277.7M	319.3M	335.3M
Liabilities And Stockholders Equity	36.0M	442.4M	373.8M	432.2M	497.0M	296.2M
Non Current Liabilities Total	47.1M	28.7M	44.8M	35.5M	32.0M	32.1M
Other Current Assets	3.2M	7.2M	7.9M	6.2M	7.1M	5.5M
Other Stockholder Equity	(33.9M)	485.7M	499.6M	667.6M	767.8M	806.2M
Total Liab	59.5M	54.5M	72.9M	63.8M	73.4M	67.1M
Net Invested Capital	(21.7M)	387.8M	300.9M	368.4M	423.7M	229.6M
Long Term Investments	7.6M	45.3M	77.1M	51.3M	59.0M	39.9M
Property Plant And Equipment Gross	3.5M	9.0M	10.7M	49.6M	57.0M	59.9M
Total Current Assets	24.3M	391.2M	260.2M	338.8M	389.7M	235.8M
Non Current Liabilities Other	2.8M	4.1M	1.7M	2.9M	3.4M	2.7M
Net Working Capital	11.9M	365.4M	232.1M	310.5M	357.1M	212.7M
Short Term Debt	654K	12.3M	1.9M	1.2M	1.4M	1.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Caribou Stock Analysis

When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Caribou Historical Balance Sheet

Caribou Biosciences Inventory

(53.5 Million)

About Caribou Balance Sheet Analysis

Caribou Biosciences Balance Sheet Chart

Total Assets

Total Current Liabilities

Common Stock Shares Outstanding

Long Term Debt

Caribou Biosciences balance sheet Correlations

Caribou Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Caribou Biosciences balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Caribou Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Property Plant And Equipment Net	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Net Tangible Assets
Other Assets	+ 1.0	Non Currrent Assets Other
Total Current Liabilities	+ 0.99	Total Assets
Net Tangible Assets	+ 0.99	Total Assets

Short Term Investments	- 0.98	Retained Earnings
Inventory	- 0.97	Non Current Assets Total
Other Stockholder Equity	- 0.97	Retained Earnings
Other Stockholder Equity	- 0.96	Inventory
Inventory	- 0.96	Non Currrent Assets Other
Retained Earnings	- 0.96	Property Plant And Equipment Net